Cori Cycle (lactate shuttle)
- Compartment
- Cytosol (muscle) + liver
- Main tissue
- Muscle/RBC <-> liver
- Rate-limiting
- Not flagged in the source
- Steps
- 2
Reaction steps
In source order, 2 total
-
1
Glucose -> 2 lactate + 2 ATP (muscle/erythrocyte)
› Notes
Anaerobic ATP supply; regenerates cytosolic NAD+ so glycolysis can continue.
-
2
Lactate -> pyruvate -> glucose (liver, 6 ATP equivalents)
Lactate dehydrogenase (LDHB) + gluconeogenic enzymes 1.1.1.27 ST-0380 Irreversible/directional NAD+ ATP GTP› Notes
Net cost of 4 ATP equivalents per cycle, shifting the energy burden to liver. Metformin-associated and hypoxic lactic acidosis reflect failure of this arm.
Showing all 2 steps.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
Advancements in early biomarkers of acute kidney injury: from traditional indicators to a paradigm shift in lactate metabolism.
Wu Q, Qiu X, Chen H. · 2026-01-13
cited 2× open access unreviewed -
2
Metabolic reprogramming in fibrosis-related diseases: underlying mechanisms and therapeutics.
Feng Y, Zhang X, Wang XJ, Chen C. · 2026-06-05
cited 1× open access unreviewed -
3
Breaking the mold: atypical lactate and ketone elevations in thyroid storm.
Bhuiya N, Kodali BV, Shah S, Riachy R. · 2026-04-29
open access unreviewed -
4
Measurement of glycolysis with heavy water labeling.
Ziari N, Hellerstein MK. · 2026-04-27
open access unreviewed -
5
Hyperlactatemia following pesticide exposure.
Ali Nour A, Jiang Z, Jiang Z, Zhou Y, Peng A, Zhang S, Cao Y. · 2026-05-01
unreviewed -
6
Formation of Liver Metastases Is Accompanied by Accelerated Musculoskeletal Deficits in LLC Tumor Hosts.
Gonzalez PO, Miller AM, Polo LFC, Plotkin LI, Pin F, Huot JR. · 2026-05-15
open access unreviewed -
7
Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances.
Fang C, Zhou S, Yu K, Zhang L, Lian W, Tie X, Chen S, Dai J, Li Q, Wang X. · 2026-05-21
open access unreviewed -
8
Lactate and lactylation: mechanisms, function, diseases, and therapeutic targets.
Wang X, Liu C, Chen Y, Fang Y, Li J, Liu Y, Pan Y, Bao S, Wang X, Liu Y, Liu H. · 2026-05-20
open access unreviewed -
9
Hepatocyte estrogen-related receptor α modulates a gluconeogenic-epigenetic crosstalk counteracting MASLD/MASH progression.
Gao J, Yang M, Duan R, Huang T, Li P, Gao L, Lu Z, Wong CW, Geng CA, Guan M. · 2026-05-08
open access unreviewed -
10
Early ADME and Preliminary Toxicity Studies of I-152, an <i>N</i>-Acetyl-l-Cysteine/<i>S</i>-Acetylcysteamine Conjugate.
Bartoccini F, Valeri A, Gregori M, Masini S, Bruschi M, Goracci L, Fraternale A, Piersanti G. · 2026-04-26
cited 1× open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.